INS and Alzheimer disease: Recently, preclinical and clinical studies have suggested that diabetes is a risk factor for AD: the levels of insulin and its receptors were found to be reduced in the brains of patients with AD, suggesting impairments in insulin signal transduction [6, 7], which are associated with memory and cognitive deficits and late-onset AD [8].